Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 36032085)

  • 1. Deciphering colorectal cancer immune microenvironment transcriptional landscape on single cell resolution - A role for immunotherapy.
    Tieng FYF; Lee LH; Ab Mutalib NS
    Front Immunol; 2022; 13():959705. PubMed ID: 36032085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personalized Immunotherapy in Colorectal Cancers: Where Do We Stand?
    Hu LF; Lan HR; Huang D; Li XM; Jin KT
    Front Oncol; 2021; 11():769305. PubMed ID: 34888246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting nucleotide metabolic pathways in colorectal cancer by integrating scRNA-seq, spatial transcriptome, and bulk RNA-seq data.
    Zhao S; Zhang P; Niu S; Xie J; Liu Y; Liu Y; Zhao N; Cheng C; Lu P
    Funct Integr Genomics; 2024 Apr; 24(2):72. PubMed ID: 38594466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revolutionizing the landscape of colorectal cancer treatment: The potential role of immune checkpoint inhibitors.
    Tolba MF
    Int J Cancer; 2020 Dec; 147(11):2996-3006. PubMed ID: 32415713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy of cancer in single-cell RNA sequencing era: A precision medicine perspective.
    Erfanian N; Derakhshani A; Nasseri S; Fereidouni M; Baradaran B; Jalili Tabrizi N; Brunetti O; Bernardini R; Silvestris N; Safarpour H
    Biomed Pharmacother; 2022 Feb; 146():112558. PubMed ID: 34953396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An integrative in-silico analysis discloses a novel molecular subset of colorectal cancer possibly eligible for immune checkpoint immunotherapy.
    Sibilio P; Belardinilli F; Licursi V; Paci P; Giannini G
    Biol Direct; 2022 May; 17(1):10. PubMed ID: 35534873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal cancer vaccines: Tumor-associated antigens
    Wagner S; Mullins CS; Linnebacher M
    World J Gastroenterol; 2018 Dec; 24(48):5418-5432. PubMed ID: 30622371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships Between Immune Landscapes, Genetic Subtypes and Responses to Immunotherapy in Colorectal Cancer.
    Picard E; Verschoor CP; Ma GW; Pawelec G
    Front Immunol; 2020; 11():369. PubMed ID: 32210966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy in human colorectal cancer: Challenges and prospective.
    Sun X; Suo J; Yan J
    World J Gastroenterol; 2016 Jul; 22(28):6362-72. PubMed ID: 27605872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential role of immunotherapy to treat colorectal cancer.
    Amin M; Lockhart AC
    Expert Opin Investig Drugs; 2015 Mar; 24(3):329-44. PubMed ID: 25519074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoantigen: A Promising Target for the Immunotherapy of Colorectal Cancer.
    Zheng Y; Fu Y; Wang PP; Ding ZY
    Dis Markers; 2022; 2022():8270305. PubMed ID: 35211210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapies catering to the unmet medical need of cold colorectal cancer.
    Yuan J; Li J; Gao C; Jiang C; Xiang Z; Wu J
    Front Immunol; 2022; 13():1022190. PubMed ID: 36275766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary clinical study of personalized neoantigen vaccine therapy for microsatellite stability (MSS)-advanced colorectal cancer.
    Yu YJ; Shan N; Li LY; Zhu YS; Lin LM; Mao CC; Hu TT; Xue XY; Su XP; Shen X; Cai ZZ
    Cancer Immunol Immunother; 2023 Jul; 72(7):2045-2056. PubMed ID: 36795124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-cell RNA sequencing in breast cancer: Understanding tumor heterogeneity and paving roads to individualized therapy.
    Ding S; Chen X; Shen K
    Cancer Commun (Lond); 2020 Aug; 40(8):329-344. PubMed ID: 32654419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Genes Related to 5-Fluorouracil Based Chemotherapy for Colorectal Cancer.
    Huang X; Ke K; Jin W; Zhu Q; Zhu Q; Mei R; Zhang R; Yu S; Shou L; Sun X; Feng J; Duan T; Mou Y; Xie T; Wu Q; Sui X
    Front Immunol; 2022; 13():887048. PubMed ID: 35784334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy: an alternative promising therapeutic approach against cancers.
    Gupta SL; Basu S; Soni V; Jaiswal RK
    Mol Biol Rep; 2022 Oct; 49(10):9903-9913. PubMed ID: 35759082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the combination of immunotherapy with conventional chemotherapy the key to increase the efficacy of colorectal cancer treatment?
    Olguin JE; Mendoza-Rodriguez MG; Sanchez-Barrera CA; Terrazas LI
    World J Gastrointest Oncol; 2023 Feb; 15(2):251-267. PubMed ID: 36908325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy strategies for mesothelioma - the role of tumor specific neoantigens in a new era of precision medicine.
    Ye L; Ma S; Robinson BW; Creaney J
    Expert Rev Respir Med; 2019 Feb; 13(2):181-192. PubMed ID: 30596292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccines for colorectal cancer: an update.
    Sarvizadeh M; Ghasemi F; Tavakoli F; Sadat Khatami S; Razi E; Sharifi H; Biouki NM; Taghizadeh M
    J Cell Biochem; 2019 Jun; 120(6):8815-8828. PubMed ID: 30536960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Therapeutic Potential of Tackling Tumor-Induced Dendritic Cell Dysfunction in Colorectal Cancer.
    Subtil B; Cambi A; Tauriello DVF; de Vries IJM
    Front Immunol; 2021; 12():724883. PubMed ID: 34691029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.